Ackermans & Van Haaren NV (GB:0GYM) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Ackermans & van Haaren NV reports a strong third quarter in 2024, maintaining momentum with core participations like DEME and Delen Private Bank, and projects a net profit exceeding 400 million euros for the year. The company bolstered its portfolio with strategic investments in V.Group and Confo Therapeutics, while also increasing stakes in Nextensa and SIPEF. AvH’s financial position remains solid with a net cash position of 294.8 million euros as of September 2024.
For further insights into GB:0GYM stock, check out TipRanks’ Stock Analysis page.